Molecular Impersonators: When Microbial Metabolites Borrow the Body’s Signals
Absurd Health Institute | Frontier Medical Concept Paper 25 | Volume 8
Series: Immune Mistaken Identities
Article type: Hypothesis and mechanistic perspective | Not an original clinical study
Manuscript prepared: 16 October 2026
Central hypothesis
Microorganisms create compounds that can resemble, imitate or antagonize host signaling molecules. The question is whether a microbiome metabolite can be understood as a distributed endocrine input—and in which contexts its presence is sufficient to change disease trajectory.
The biological route
Microbial conversion of bile acids changes ligands for FXR and TGR5; tryptophan metabolites interact with host receptors; short-chain fatty acids influence immune-cell metabolism and intestinal epithelium. These mechanisms illustrate cross-kingdom pharmacology without implying that every metabolite is pathogenic. Spatial concentration, receptor affinity and transport are crucial: stool abundance does not establish meaningful concentrations at a distant receptor.
An illustrative scenario
Microbial production of a receptor ligand is not equivalent to a measurable effect in distant brain tissue. One has to determine how much is produced, where it enters the circulation, how rapidly it is cleared and whether its target receptor is occupied at physiological concentrations. A stool sequencing report cannot answer those questions by itself. The pathway needs a molecular accounting from organism to outcome.
Alternative explanations and limits
Metabolite signatures can reflect diet, transit, medication, inflammation or disease rather than cause it. Taxonomic microbiome differences alone rarely identify active biochemical mechanisms, and simplistic good-bacteria/bad-bacteria narratives obscure strain-level biology.
What would change the conclusion?
The strongest test tracks a named molecule from a defined microbial pathway into host exposure and receptor activity, then shows a relevant functional effect independent of confounding. If receptor activation is too weak at physiological concentrations, the proposed causal route is weakened.
The distinctive prediction
The strongest microbial impersonator hypothesis would connect strain-specific biosynthesis, circulating metabolite concentration and receptor occupancy with a functional effect. A change in microbial species abundance alone is several causal steps short of proof.
Clinical interpretation
Clinically this favors substance-specific, mechanistic investigation over indiscriminate probiotics, antimicrobials or assertions that microbiome imbalance explains all chronic symptoms.
Selected scientific reading
The references below establish relevant background mechanisms or examples; they do not independently verify the proposed synthesis.
Source and disclosure note
Conceptual hypothesis, not patient-level research, a validated diagnosis, a systematic review or a treatment protocol. Background references do not directly establish the proposed thesis.